Fundraising Fox

BioPharmX

Menlo Park, US · Founded 2014 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

BioPharmX was founded in 2014 by Anja Krammer and JAMES PEKARSKY.

AK
Anja KrammerPresident and Director
JP
JAMES PEKARSKYCEO and CFO
GK
Greg KitchenerChief Financial Officer

Board

MH
Michael HubbardChairman
SM
Stephen MorlockBoard director

Investors · 1

Korea Investment PartnersreportedSeoul · $973K – $50M

Reported raises · per SEC filings

Form D private placements

$11.7M disclosed across 7 of 8 rounds · 2012–2022

▶Undisclosed amountofferedOct 2022 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph LuccheseExecutive Officer
  • Alan M. MendelsohnExecutive Officer
  • Edward J. SitarDirector
  • David E. CohenDirector
  • Lubor GaalDirector
  • John KoconisExecutive Officer, Director
  • Gianluca PirozziDirector
Placement agents
H.C. Wainwright & Co. LLC
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$930KraisedOct 2016 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Greg KitchenerExecutive Officer
  • Anja KrammerExecutive Officer, Director
  • Michael HubbardDirector
  • Stephen MorlockDirector
Offering amount
$930K
Amount sold
$930K
Sales commissions
$55.8K
Placement agents
Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC
First sale
Sep 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$508.5KraisedMar 2015 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Anja KrammerExecutive Officer, Director
  • Kin ChanExecutive Officer
  • Michael HubbardDirector
  • Ping WangDirector
  • James PekarskyExecutive Officer, Director
Offering amount
$508.5K
Amount sold
$508.5K
First sale
Jan 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.9MraisedMar 2015 · 51 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES PEKARSKYExecutive Officer, Director
  • PING WANGDirector
  • ANJA KRAMMERExecutive Officer, Director
  • KIN CHANExecutive Officer
  • MICHAEL HUBBARDDirector
Offering amount
$18.6M
Amount sold
$7.9M
Finders' fees
$227.2K
First sale
Apr 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$134.3KraisedMar 2015 · 16 investors · Pharmaceuticals
Officers, directors & promoters on the filing
  • James PekarskyExecutive Officer, Director
  • Kin ChanExecutive Officer
  • Ping WangDirector
  • Anja KrammerExecutive Officer, Director
  • Michael HubbardDirector
Offering amount
$134.3K
Amount sold
$134.3K
First sale
Sep 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
05
Full filing on SEC EDGAR ↗
▶$1.8MraisedMar 2015 · 25 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ping WangDirector
  • James PekarskyExecutive Officer, Director
  • Anja KrammerExecutive Officer, Director
  • Michael HubbardDirector
  • Kin ChanExecutive Officer
Offering amount
$1.8M
Amount sold
$1.8M
First sale
Aug 2012
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7KraisedJan 2014 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • ANJA KRAMMERExecutive Officer, Director
  • JAMES PEKARSKYExecutive Officer, Director
Offering amount
$7K
Amount sold
$7K
First sale
Jan 2014
Incorporated
Corporation, Nevada, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedJan 2014 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES PEKARSKYExecutive Officer, Director
  • ANJA KRAMMERExecutive Officer, Director
Offering amount
$500K
Amount sold
$500K
First sale
Jan 2014
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

BioPharmX Corporation - InvestSnipsinvestsnips.com · Jun 2024BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreementprnewswire.com · Jan 2020What Kind Of Investor Owns Most Of BioPharmX Corporation (NYSEMKT:BPMX)?finance.yahoo.com · Sep 2019BioPharmX Announces Pricing Of Public Offering To Raise $4.3 Million - BioSpacebiospace.com · Mar 2016Bay Area Startup BioPharmX Locks In $12 Million - BioSpacebiospace.com · Nov 2014

Frequently asked questions

Who founded BioPharmX?
BioPharmX was founded by Anja Krammer, JAMES PEKARSKY in 2014.
Who are BioPharmX's investors?
BioPharmX's investors include Korea Investment Partners.
How much funding has BioPharmX raised?
BioPharmX has disclosed $11.7M raised across 7 of its 8 known rounds.
Where is BioPharmX headquartered?
BioPharmX is headquartered in Menlo Park, US.